The integration seeks to enable multi-omic biomarker detection at unprecedented speed, scale, and cost SAN DIEGO -- Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, today announced successful deployment of the first of its RAPTOR instruments integrated with industry-leading TotalSeq™ antibodies from BioLegend, part of Revvity. This marks the [...]

Marlborough, MA – Scitara, a market-leading innovator in laboratory digital transformation, has announced an agreement with Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software. Under the agreement, Waters has licensed Scitara’s Digital Lab Exchange DLX™ cloud platform to communicate with Waters’ Empower™ Chromatography Data System and waters_connect™ Lab Informatics Platform to [...]

Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced a collaboration with Exactis Innovation, based in Montreal, Quebec, who will contribute to cancer research and data-driven decision-making through SOPHiA GENETICS’ multimodal real-world data offering. Exactis Innovation is a non-profit network of hospital partners across Canada dedicated [...]

IRVINE, Calif. - Zymo Research, a leading provider of microbiology research tools, proudly announces the official launch of its Metagenome Assembly Analysis Service, utilizing PacBio HiFi sequencing. This groundbreaking service offers researchers an easier way to study intricate microbial communities. While DNA sequencing and assembly have become commonplace, repetitive sequences can cause mis-assemblies and gaps, giving an [...]

New Advancement Builds on 25-Year Commitment to T-Cell Research INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with first-to-market concepts to help laboratories achieve goals faster and with greater accuracy. The company today announces it has developed the first commercially available anti-TRBC2 conjugated antibody for flow cytometry, [...]

Company to share vision for artificial intelligence in life sciences and highlight results of technology evaluation initiatives at J.P. Morgan Healthcare Conference MENLO PARK, Calif. – Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced its achievement of key commercial milestones for the REM-I platform. Deepcell also [...]

Group press release | Zürich, Switzerland  Through the acquisition of Canadian company Real Tech, ABB expands its strong presence in the water segment and complements its portfolio with optical sensor technology critical for the age of smart water Real Tech is a market leader in real-time water quality monitoring and testing with more than 10,000 [...]

Element has exceeded 160 orders, generating more than $25 million in revenue in 2023 Element announces roadmap for suite of new products in 2024 SAN DIEGO – Element Biosciences, Inc., developer of pioneering technologies to empower science, has received over 160 commercial orders of its AVITI benchtop sequencer and expanded its installed base to 112 instruments, the company announced [...]

New single-cell datasets available online and in Chan Zuckerberg Cell by Gene Discover database as expanded product portfolio begins shipping to customers SAN DIEGO--Scale Biosciences (ScaleBio™), an innovator in exponentially scaled single-cell sequencing, providing instrument-free workflows and accessible cost, today announced the availability of three new datasets showcasing the performance of its newly released products, [...]

New Advancement Builds on 25-Year Commitment to T-Cell Research   INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with first-to-market concepts to help laboratories achieve goals faster and with greater accuracy. The company today announces it has developed the first commercially available anti-TRBC2 conjugated [...]